Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Cardiol ; 44(1): 67-74, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36273322

RESUMO

We evaluated the association between implementation of state-mandated pulse oximetry screening (POS) and rates of emergency hospitalizations among infants with Critical Congenital Heart Disease (CCHD) and assessed differences in that association across race/ethnicity. We hypothesized that emergency hospitalizations among infants with CCHD decreased after implementation of mandated POS and that the reduction was larger among racial and ethnic minorities compared to non-Hispanic Whites. We utilized statewide inpatient databases from Arizona, California, Kentucky, New Jersey, New York, and Washington State (2010-2014). A difference-in-differences model with negative binomial regression was used. We identified patients with CCHD whose hospitalizations between three days and three months of life were coded as "emergency" or "urgent" or occurred through the emergency department. Numbers of emergency hospitalizations aggregated by month and state were used as outcomes. The intervention variable was an implementation of state-mandated POS. Difference in association across race/ethnicity was evaluated with interaction terms between the binary variable indicating the mandatory policy period and each race/ethnicity group. The model was adjusted for state-specific variables, such as percent of female infants and percent of private insurance. We identified 9,147 CCHD emergency hospitalizations. Among non-Hispanic Whites, there was a 22% (Confidence Interval [CI] 6%-36%) decline in CCHD emergency hospitalizations after implementation of mandated POS, on average. This decline was 65% less among non-Hispanic Blacks compared to non-Hispanic Whites. Our study detected an attenuated association with decreased number of emergency hospitalizations among Black compared to White infants. Further research is needed to clarify this disparity.


Assuntos
Cardiopatias Congênitas , Triagem Neonatal , Recém-Nascido , Lactente , Humanos , Feminino , Cardiopatias Congênitas/diagnóstico , Hospitalização , Oximetria , New York
2.
Biochem Mol Biol Educ ; 46(1): 54-57, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-29105928

RESUMO

The 8 studs on a 2 × 4 Lego brick conveniently represent the outer shell of electrons for carbon, nitrogen, and oxygen atoms. We used Lego bricks to model these atoms, which are then joined together to form molecules by following the Lewis octet rule. A variety of small biological molecules can be modeled in this way, such as most amino acids, fatty acids, glucose, and various intermediate metabolites. Model building with these familiar toys can be a helpful, hands-on exercise for learning-or re-learning-biochemical pathways. © 2017 by The International Union of Biochemistry and Molecular Biology, 46(1):54-57, 2018.


Assuntos
Aminoácidos/metabolismo , Fenômenos Bioquímicos , Ácidos Graxos/metabolismo , Glucose/metabolismo , Modelos Moleculares , Plásticos , Jogos e Brinquedos , Ensino/educação , Aminoácidos/química , Carbono/química , Carbono/metabolismo , Elétrons , Ácidos Graxos/química , Glucose/química , Humanos , Aprendizagem , Nitrogênio/química , Nitrogênio/metabolismo , Oxigênio/química , Oxigênio/metabolismo
3.
Pediatrics ; 132(3): 445-53, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23958770

RESUMO

BACKGROUND AND OBJECTIVES: Latino-white disparities in age at autism spectrum disorder (ASD) diagnosis may be modified by primary care pediatrician (PCP) practices and beliefs. The objectives of this study were to assess ASD and developmental screening practices, attitudes toward ASD identification in Latino children, and barriers to ASD identification for Latino children, in a sample of 267 California PCPs. METHODS: In mail-based PCP survey, we assessed rates of bilingual general developmental and ASD screening, perceptions of parent ASD knowledge in Latino and white families, reports of difficulty assessing for ASDs in Latino and white children, and perceptions of barriers to early ASD identification for Latinos. RESULTS: Although 81% of PCPs offered some form of developmental screening, 29% of PCPs offered Spanish ASD screening per American Academy of Pediatrics guidelines, and only 10% offered both Spanish general developmental and Spanish ASD screening per American Academy of Pediatrics guidelines. Most PCPs thought that Latino (English and Spanish primary family language) parents were less knowledgeable about ASDs than white parents. PCPs had more difficulty assessing ASD risk for Latino children with Spanish primary family language than for white children, even when the PCP conducted recommended ASD screening or had >25% Latino patients. The most frequent barrier to ASD identification in Latinos was access to developmental specialists. CONCLUSIONS: Multiple factors in the primary care setting may contribute to delayed ASD identification for Latinos. Promoting language-appropriate screening, disseminating culturally appropriate ASD materials to Latino families, improving the specialist workforce, and providing PCP support in screening and referral of Latino children may be important ways to reduce racial and ethnic differences in care.


Assuntos
Transtornos Globais do Desenvolvimento Infantil/diagnóstico , Transtornos Globais do Desenvolvimento Infantil/etnologia , Hispânico ou Latino/psicologia , Pediatria , População Branca/psicologia , Atitude do Pessoal de Saúde , California , Criança , Transtornos Globais do Desenvolvimento Infantil/psicologia , Barreiras de Comunicação , Cultura , Deficiências do Desenvolvimento/diagnóstico , Deficiências do Desenvolvimento/etnologia , Deficiências do Desenvolvimento/psicologia , Diagnóstico Precoce , Fidelidade a Diretrizes , Letramento em Saúde , Acessibilidade aos Serviços de Saúde , Inquéritos Epidemiológicos , Disparidades em Assistência à Saúde , Humanos , Programas de Rastreamento , Multilinguismo , Atenção Primária à Saúde , Fatores de Risco
4.
Proc Natl Acad Sci U S A ; 104(31): 12849-54, 2007 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-17652175

RESUMO

We have tested a hypothesis that the natural product curcuminoids, which has epidemiologic and experimental rationale for use in AD, may improve the innate immune system and increase amyloid-beta (Abeta) clearance from the brain of patients with sporadic Alzheimer's disease (AD). Macrophages of a majority of AD patients do not transport Abeta into endosomes and lysosomes, and AD monocytes do not efficiently clear Abeta from the sections of AD brain, although they phagocytize bacteria. In contrast, macrophages of normal subjects transport Abeta to endosomes and lysosomes, and monocytes of these subjects clear Abeta in AD brain sections. Upon Abeta stimulation, mononuclear cells of normal subjects up-regulate the transcription of beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (MGAT3) (P < 0.001) and other genes, including Toll like receptors (TLRs), whereas mononuclear cells of AD patients generally down-regulate these genes. Defective phagocytosis of Abeta may be related to down-regulation of MGAT3, as suggested by inhibition of phagocytosis by using MGAT3 siRNA and correlation analysis. Transcription of TLR3, bditTLR4, TLR5, bditTLR7, TLR8, TLR9, and TLR10 upon Abeta stimulation is severely depressed in mononuclear cells of AD patients in comparison to those of control subjects. In mononuclear cells of some AD patients, the curcuminoid compound bisdemethoxycurcumin may enhance defective phagocytosis of Abeta, the transcription of MGAT3 and TLRs, and the translation of TLR2-4. Thus, bisdemethoxycurcumin may correct immune defects of AD patients and provide a previously uncharacterized approach to AD immunotherapy.


Assuntos
Aciltransferases/genética , Doença de Alzheimer/genética , Doença de Alzheimer/imunologia , Curcumina/análogos & derivados , Imunidade Inata/imunologia , Receptores Toll-Like/genética , Transcrição Gênica/efeitos dos fármacos , Aciltransferases/metabolismo , Idoso , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/metabolismo , Comunicação Celular , Curcumina/farmacologia , Curcumina/uso terapêutico , Diarileptanoides , Regulação para Baixo/efeitos dos fármacos , Humanos , Imunidade Inata/efeitos dos fármacos , Imunoterapia , Linfócitos/efeitos dos fármacos , Linfócitos/metabolismo , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Macrófagos/patologia , Fagocitose/efeitos dos fármacos , Biossíntese de Proteínas , Transporte Proteico , RNA Interferente Pequeno/genética , Transcrição Gênica/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...